Anson Funds Management LP - Q4 2019 holdings

$48.7 Million is the total value of Anson Funds Management LP's 81 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was - .

 Value Shares↓ Weighting
TLRY NewTILRAY INC$13,907,0001,258,079
+100.0%
16.14%
UVXY NewPROSHARES TR IIput$6,445,000500,000
+100.0%
7.48%
AEM NewAGNICO EAGLE MINES LTD$5,999,00075,000
+100.0%
6.96%
CAG NewCONAGRA BRANDS INCcall$3,424,000100,000
+100.0%
3.97%
GOLD NewBARRICK GOLD CORPORATION$1,466,00060,800
+100.0%
1.70%
COR NewCORESITE RLTY CORP$1,368,00012,200
+100.0%
1.59%
HHC NewHOWARD HUGHES CORP$1,293,00010,200
+100.0%
1.50%
MFC NewMANULIFE FINL CORP$970,00036,800
+100.0%
1.13%
FPI NewFARMLAND PARTNERS INC$915,000135,000
+100.0%
1.06%
BHC NewBAUSCH HEALTH COS INC$913,00030,500
+100.0%
1.06%
CHEKW NewCHECK CAP LTD*w exp 02/28/2024$833,000484,196
+100.0%
0.97%
MA NewMASTERCARD INCcl a$806,0002,700
+100.0%
0.94%
GOOG NewALPHABET INCcap stk cl c$802,000600
+100.0%
0.93%
V NewVISA INC$770,0004,100
+100.0%
0.89%
LOW NewLOWES COS INC$766,0006,400
+100.0%
0.89%
WFC NewWELLS FARGO CO NEW$753,00014,000
+100.0%
0.87%
SPGI NewS&P GLOBAL INC$737,0002,700
+100.0%
0.86%
SCHW NewTHE CHARLES SCHWAB CORPORATION$713,00015,000
+100.0%
0.83%
VOYA NewVOYA FINL INC$707,00011,600
+100.0%
0.82%
GS NewGOLDMAN SACHS GROUP INC$690,0003,000
+100.0%
0.80%
BAC NewBANK AMER CORP$662,00018,800
+100.0%
0.77%
CNQ NewCANADIAN NAT RES LTD$655,00015,600
+100.0%
0.76%
GSK NewGLAXOSMITHKLINE PLC-SPON ADRsponsored adr$648,00013,800
+100.0%
0.75%
BABA NewALIBABA GROUP HLDG LTDsponsored ads$636,0003,000
+100.0%
0.74%
RIO NewRIO TINTO PLCsponsored adr$635,00010,700
+100.0%
0.74%
UNH NewUNITEDHEALTH GROUP INC$617,0002,100
+100.0%
0.72%
FB NewFACEBOOK INCcl a$616,0003,000
+100.0%
0.72%
EQX NewEQUINOX GOLD CORP$599,00060,000
+100.0%
0.70%
EKSO NewEKSO BIONICS HLDGS INC$593,0001,516,986
+100.0%
0.69%
HCA NewHCA HEALTHCARE INC$591,0004,000
+100.0%
0.69%
PXD NewPIONEER NAT RES CO$590,0003,900
+100.0%
0.68%
TSN NewTYSON FOODS INCcl a$546,0006,000
+100.0%
0.63%
KMI NewKINDER MORGAN INC DEL$538,00025,400
+100.0%
0.62%
CKPT NewCHECKPOINT THERAPEUTICS INC$535,000311,249
+100.0%
0.62%
SU NewSUNCOR ENERGY INC NEW$522,00015,900
+100.0%
0.61%
MSFT NewMICROSOFT CORP$520,0003,300
+100.0%
0.60%
CLRBZ NewCELLECTAR BIOSCIENCES INC*w exp 04/20/2024$518,000233,330
+100.0%
0.60%
MAS NewMASCO CORP$518,00010,800
+100.0%
0.60%
EA NewELECTRONIC ARTS INC$516,0004,800
+100.0%
0.60%
BMY NewBRISTOL MYERS SQUIBB CO$514,0008,000
+100.0%
0.60%
GPN NewGLOBAL PAYMENTS INC$511,0002,800
+100.0%
0.59%
ZBH NewZIMMER BIOMET HLDGS INC$509,0003,400
+100.0%
0.59%
UNP NewUNION PACIFIC CORP$506,0002,800
+100.0%
0.59%
QCOM NewQUALCOMM INC$503,0005,700
+100.0%
0.58%
FMC NewF M C CORP$499,0005,000
+100.0%
0.58%
JNJ NewJOHNSON & JOHNSON$496,0003,400
+100.0%
0.58%
STNG NewSCORPIO TANKERS INC$445,00011,300
+100.0%
0.52%
EZPW NewEZCORP INCcl a non vtg$401,00058,825
+100.0%
0.46%
INFO NewIHS MARKIT LTD$384,0005,100
+100.0%
0.45%
DIS NewDISNEY WALT CO$376,0002,600
+100.0%
0.44%
NewAKERS BIOSCIENCES INC$350,000109,500
+100.0%
0.41%
PSNL NewPERSONALIS INC$333,00030,525
+100.0%
0.39%
IPI NewINTREPID POTASH INC$320,000118,245
+100.0%
0.37%
NTGN NewNEON THERAPEUTICS INC$319,000270,120
+100.0%
0.37%
AFMD NewAFFIMED N V$295,000107,510
+100.0%
0.34%
CTSO NewCYTOSORBENTS CORP$287,00074,440
+100.0%
0.33%
DRTT NewDIRTT ENVIRONMENTAL SOLUT LTD$251,00058,973
+100.0%
0.29%
SONM NewSONIM TECHNOLOGIES INC$249,00068,530
+100.0%
0.29%
SRNE NewSORRENTO THERAPEUTICS INCput$232,00068,600
+100.0%
0.27%
LOV NewSPARK NETWORKS SEsponsored adr$225,00049,567
+100.0%
0.26%
CVIAQ NewCOVIA HLDGS CORP$208,000102,117
+100.0%
0.24%
THTX NewTHERATECHNOLOGIES INC$174,00040,735
+100.0%
0.20%
NewLIGHTBRIDGE CORP$125,00027,848
+100.0%
0.14%
ASRT NewASSERTIO THERAPEUTICS INC$108,00086,767
+100.0%
0.12%
UMRX NewUNUM THERAPEUTICS INC$97,000135,185
+100.0%
0.11%
NewSAFE T GROUP LTDsponsord ads$95,00031,532
+100.0%
0.11%
BIOC NewBIOCEPT INC$11,00037,147
+100.0%
0.01%
LPCN NewLIPOCINE INC NEW$8,00021,400
+100.0%
0.01%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

  • Anson Advisors Inc. #1
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-02-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
MICROSOFT CORP27Q3 20238.7%
BK OF AMERICA CORP24Q3 202315.9%
JPMORGAN CHASE & CO17Q2 20222.2%
MEDIGUS LTD17Q1 20230.0%
WISDOMTREE TR15Q2 20184.0%
RANDGOLD RES LTD15Q2 20183.3%
GRANITE REAL ESTATE INVT TR15Q3 20231.3%
BROOKFIELD ASSET MGMT INC15Q3 20221.3%
CENTRAL FD CDA LTD14Q1 20181.6%
MEI PHARMA INC14Q1 20231.2%

View Anson Funds Management LP's complete holdings history.

Latest significant ownerships (13-D/G)
Anson Funds Management LP Q4 2019 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Appreciate Holdings, Inc.Sold outFebruary 14, 202300.0%
Equity Distribution Acquisition Corp.Sold outFebruary 14, 202300.0%
GO Acquisition Corp.Sold outFebruary 14, 202300.0%
LogicMark, Inc.February 14, 2023987,3999.9%
Model Performance Acquisition CorpSold outFebruary 14, 202300.0%
Mudrick Capital Acquisition Corp. IISold outFebruary 14, 202300.0%
View, Inc.February 14, 202324,597,1859.9%
Amarantus Bioscience Holdings, Inc.April 18, 202214,176,4245.0%
Dune Acquisition CorpFebruary 11, 2022100,0000.6%
PROPTECH INVESTMENT CORP. IIFebruary 11, 20221,184,2765.2%

View Anson Funds Management LP's complete significant-ownership history.

Latest filings
TypeFiled
SC 13D/A2024-04-05
DFAN14A2024-04-04
42024-02-26
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G2024-02-14
SC 13G2024-02-14
SC 13G2024-02-14
SC 13G2024-02-14

View Anson Funds Management LP's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (48719000.0 != 86150000.0)

Export Anson Funds Management LP's holdings